Explore Watchlists Pricing

SYSMEX CORPORATION (6869) Income statement

Market cap

¥940.1B

P/E ratio

25.8x

Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	134,743	145,577	184,538	221,376	253,157	249,899	281,935	293,506	301,980	305,073	363,780	410,502	461,510	508,643	500,006
Revenue growth (%)	-
Cost of revenue	-	-	-	95,358	102,063	62,604	66,537	131,899	142,173	150,770	173,195	194,419	219,013	236,665	244,324
Gross profit	-	-	-	126,018	151,093	76,444	77,342	161,606	159,807	154,302	190,585	216,082	242,497	271,977	255,681
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	81,606	94,131	45,478	44,905	81,230	83,545	80,839	94,235	112,371	133,798	150,848	164,351
Operating income	-	-	-	44,411	56,962	30,965	32,437	61,282	55,284	51,792	67,416	73,679	78,382	87,583	20,730
Income before tax	19,130	22,976	33,782	45,955	54,342	48,946	58,117	57,955	49,433	48,033	64,346	68,713	74,600	79,221	41,041
Pretax margin (%)	14.2	15.8	18.3	20.8	21.5	19.6	20.6	19.7	16.4	15.7	17.7	16.7	16.2	15.6	8.2
Provision for income taxes	-	-	-	19,089	18,426	6,968	8,204	16,789	14,619	14,930	20,274	22,988	24,826	25,645	13,676
Effective tax rate (%)	-	-	-
Net income	7,433	9,266	17,356	26,638	36,233	40,636	39,222	41,224	34,883	33,142	44,093	45,784	49,639	53,669	28,029
Earnings per share	116.85	68.79	99.47	128.49	174.42	195.31	188.29	197.6	167.1	158.65	210.88	218.83	79.27	86.07	44.98
Diluted EPS	116.63	68.53	99.16	128.02	173.71	178.65	118.11	197.29	166.93	158.39	210.49	218.73	79.24	86.05	56.89
Dividend payout ratio (%)	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	72	72	76	82	84	32	38